STOCK TITAN
  1. Home
  2. Sec-filings
  3. SVCO
  4. [Form 4] Silvaco Group, Inc. Insider Trading Activity

Silvaco (SVCO) CFO Buys 5,100 Shares; Granted 415,914 RSUs

Filing Impact
(Neutral)
Filing Sentiment
(Positive)
Form Type
4

Rhea-AI Filing Summary

Silvaco Group, Inc. (SVCO) insider filing shows the company CFO increased ownership through two transactions and received a substantial restricted stock unit grant. On 09/15/2025 the reporting person purchased 5,100 shares at $5.03, bringing direct ownership to 8,493 shares. On 10/01/2025 the reporting person was granted 415,914 Restricted Stock Units (RSUs) with 0 per-share price; after the grant total direct beneficial ownership rose to 424,407 shares. The RSUs vest 25% on the first anniversary and then in twelve equal quarterly installments, fully vesting on 10/01/2029. The filing is signed by an attorney-in-fact on 10/08/2025.

Positive

  • Large RSU grant of 415,914 shares aligns CFO with long‑term shareholders
  • Direct ownership increased to 424,407 shares after grant
  • Vesting schedule (25% after one year, then quarterly) supports retention through 10/01/2029
  • Open‑market purchase of 5,100 shares at $5.03 signals personal investment

Negative

  • Potential future dilution when 415,914 RSUs settle into common shares through 10/01/2029
  • Filing does not state whether settled RSUs will be issued from treasury stock or newly issued shares, leaving dilution impact unclear

Insights

CFO received a large time‑based RSU grant and made a small open‑market purchase.

The 415,914 RSU grant materially increases direct beneficial ownership to 424,407 shares, aligning the CFO’s incentives with long‑term shareholder value through multi‑year vesting to 10/01/2029. Time‑based vesting reduces immediate dilution but creates future issuance when RSUs settle into common shares.

Dependencies include future share issuance practices and whether the company issues new shares on settlement or uses treasury stock; monitor annual proxy filings and equity‑compensation disclosure over the next four years for dilution impact.

Grant structure is standard: 25% first‑year cliff, then quarterly vesting over three additional years.

The RSU grant carries no exercise price and vests over four years, which is common for executive retention. The small open‑market purchase of 5,100 shares at $5.03 shows a modest additional direct stake but is not material relative to the RSU grant size.

Watch reported share count and outstanding equity in quarterly filings to quantify dilution from settlement events expected through 10/01/2029.

Insider Zegarelli Christopher John
Role Chief Financial Officer
Bought 5,100 shs ($26K)
Type Security Shares Price Value
Grant/Award Common Stock 415,914 $0.00 --
Purchase Common Stock 5,100 $5.03 $26K
Holdings After Transaction: Common Stock — 424,407 shares (Direct)
Footnotes (1)
  1. [object Object]
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Zegarelli Christopher John
(Last) (First) (Middle)
C/O SILVACO GROUP, INC.
4701 PATRICK HENRY DRIVE, BUILDING #23
(Street)
SANTA CLARA CA 95054
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Silvaco Group, Inc. [ SVCO ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
09/15/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/15/2025 P 5,100 A $5.03 8,493 D
Common Stock 10/01/2025 A 415,914(1) A $0 424,407 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents Restricted Stock Units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs were granted on October 1, 2025, and 25% of the RSUs shall vest on the first anniversary of the grant date, while the remaining RSUs shall vest in twelve equal quarterly installments until fully vested on October 1, 2029.
Remarks:
/s/ Candace Jackson, as Attorney-in-Fact 10/08/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What transactions did the SVCO reporting person disclose?

The reporting person purchased 5,100 shares at $5.03 on 09/15/2025 and was granted 415,914 RSUs on 10/01/2025.

How many shares does the SVCO reporting person beneficially own after these transactions?

Total direct beneficial ownership reported is 424,407 shares following the transactions.

What are the RSU vesting terms for the SVCO grant?

The RSUs vest 25% on the first anniversary and then in twelve equal quarterly installments, fully vesting on 10/01/2029.

Was there any cash paid for the RSUs?

The grant is reported at a $0 per‑share price, consistent with standard RSU awards.

Who signed the Form 4 and when was it filed?

The Form 4 was signed by an attorney‑in‑fact, Candace Jackson, on 10/08/2025.